ISM - MSBV - PARTIAL_RETIREMENT -31st Oct 25

Summary by AI BETAClose X

Morgan Stanley B.V. announced a partial cancellation of several ISINs/CUSIPs, with a settlement date of November 4, 2025. The unwind amount for XS2846547490 is 10,000.00, leaving an outstanding amount of 476,000.00. For XS2893934716, the unwind amount is 30,000.00, with an outstanding amount of 1,714,000.00. XS2893953930 has an unwind amount of 76,000.00 and an outstanding amount of 413,000.00. The unwind amount for XS2918025243 is 100,000.00, resulting in an outstanding amount of 950,000.00. Finally, XS2877376371 has an unwind amount of 350,000.00, leaving an outstanding amount of 150,000.00.

Disclaimer*

Morgan Stanley B.V.
31 October 2025
 

 

Morgan Stanley & Co. International plc

25 Cabot Square

Canary Wharf

London E14 4QA, England

 

 

October 31, 2025

 

Notice of Partial Cancellation

 

 

Dear Sir/Madam:

 

Please note that there has been a Partial Cancellation by the issuer for the following ISIN(s) / CUSIP(s):

 

ISIN(s)/CUSIP(s)

Issuer

Unwind Amount

Outstanding Amount*

Settlement Date

XS2846547490

MORGAN STANLEY B.V.

10,000.00

476,000.00

04-Nov-2025

XS2893934716

MORGAN STANLEY B.V.

30,000.00

1,714,000.00

04-Nov-2025

XS2893953930

MORGAN STANLEY B.V.

76,000.00

413,000.00

04-Nov-2025

XS2918025243

MORGAN STANLEY B.V.

100,000.00

950,000.00

04-Nov-2025

XS2877376371

MORGAN STANLEY B.V.

350,000.00

150,000.00

04-Nov-2025

 

*Outstanding Amount reflects the Outstanding Issuance Amount post notification event.

 

In case of any questions do not hesitate to contact us for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings